Client News

Abivax Presents First-Half 2024 Financial Results

Secarna Pharmaceuticals will Present Data at 6th Inflammasome Therapeutics Summit Demonstrating the Potential of ASOs to Target the Expression of NLRP3

Syntekabio to Highlight its Cutting-edge AI-driven Discovery Solutions at BioTechX

Medigene AG Announces U.S. FDA Clearance of IND Application for MDG1015, a First-in-Class, Third Generation T Cell Receptor Engineered T Cell (TCR-T) Therapy for Multiple Solid Tumor Indications

Secarna Establishes Scientific Advisory Board with Leading Oncology Experts Prof. Dr. Eggermont and Prof. Dr. Zippelius

Mainz Biomed Partners with Liquid Biosciences to Leverage the Power of Artificial Intelligence for the Expansion and Optimization of Biomarker Selection for PancAlert

InflaRx Presents New Preclinical Findings for INF904 at the 19th European Meeting on Complement in Human Diseases

Rentschler Biopharma Introduces New Lentiviral Vector Manufacturing Toolbox for Advanced Therapies

Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device

Syntekabio Introduces Develop Now, Pay Later with AI-powered STB LaunchPad Program